Delivery Order SPE2DB20D3103-SPE2DB25FM8J2
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$90K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $111,923.49 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,160.78 firm fixed-price delivery order is for MENQUADFI VIAL 0.5ML medical supplies, with a performance period through February 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,301.12 firm-fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has an ultimate completion date of August 26, 2022 and was awarded on August 25, 2022. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,794.69 firm fixed-price delivery order contract is for MENQUADFI VIAL 0.5ML medical supplies, with a performance period through January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,947.55 firm fixed price delivery order is for MENQUADFI VIAL 0.5ML medical supplies, with a period of performance through January 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,628.85 firm fixed-price delivery order is for the procurement of MENQUADFI VIAL 0.5ML medical products. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, identified as SPE2DB20D7059|SPE2DB25FQAU8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,903.08 firm fixed-price delivery order is for the procurement of MENQUADFI VIAL 0.5ML medical supplies. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,104.59 firm fixed-price delivery order is for the supply of medical products, including MENQUADFI VIAL 0.5ML. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,747.06 firm fixed-price delivery order (SPE2DB22D1052|SPE2DB25FU7XV) is for the supply of MENQUADFI VIAL 0.5ML medical products, with an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.73 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of July 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC)...